Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
PCR and NGS-Based Molecular Diagnostics market report explains the definition, types, applications, major countries, and major players of the PCR and NGS-Based Molecular Diagnostics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Burning Rock
Bioo Scientific
Qiagen
Pillar Biosciences
Agilent
Paragon Genomics
LC-Bio Technologies (Hangzhou) CO Ltd
iGen Technologies
Thermofisher
Roche
Illumine
By Type:
Biomarker Discovery
Blood Sample Testig
Others
By End-User:
Hospitals
Academics/Research Institutions
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global PCR and NGS-Based Molecular Diagnostics Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 PCR and NGS-Based Molecular Diagnostics Outlook to 2028- Original Forecasts
-
2.2 PCR and NGS-Based Molecular Diagnostics Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term PCR and NGS-Based Molecular Diagnostics Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global PCR and NGS-Based Molecular Diagnostics Market- Recent Developments
-
6.1 PCR and NGS-Based Molecular Diagnostics Market News and Developments
-
6.2 PCR and NGS-Based Molecular Diagnostics Market Deals Landscape
7 PCR and NGS-Based Molecular Diagnostics Raw Materials and Cost Structure Analysis
-
7.1 PCR and NGS-Based Molecular Diagnostics Key Raw Materials
-
7.2 PCR and NGS-Based Molecular Diagnostics Price Trend of Key Raw Materials
-
7.3 PCR and NGS-Based Molecular Diagnostics Key Suppliers of Raw Materials
-
7.4 PCR and NGS-Based Molecular Diagnostics Market Concentration Rate of Raw Materials
-
7.5 PCR and NGS-Based Molecular Diagnostics Cost Structure Analysis
-
7.5.1 PCR and NGS-Based Molecular Diagnostics Raw Materials Analysis
-
7.5.2 PCR and NGS-Based Molecular Diagnostics Labor Cost Analysis
-
7.5.3 PCR and NGS-Based Molecular Diagnostics Manufacturing Expenses Analysis
8 Global PCR and NGS-Based Molecular Diagnostics Import and Export Analysis (Top 10 Countries)
-
8.1 Global PCR and NGS-Based Molecular Diagnostics Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global PCR and NGS-Based Molecular Diagnostics Export by Region (Top 10 Countries) (2017-2028)
9 Global PCR and NGS-Based Molecular Diagnostics Market Outlook by Types and Applications to 2022
-
9.1 Global PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Biomarker Discovery Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Blood Sample Testig Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Academics/Research Institutions Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise PCR and NGS-Based Molecular Diagnostics Market Analysis and Outlook till 2022
-
10.1 Global PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.2.2 Canada PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.2.3 Mexico PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.3.2 UK PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.3.3 Spain PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.3.4 Belgium PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.3.5 France PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.3.6 Italy PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.3.7 Denmark PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.3.8 Finland PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.3.9 Norway PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.3.10 Sweden PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.3.11 Poland PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.3.12 Russia PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.3.13 Turkey PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.4.2 Japan PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.4.3 India PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.4.4 South Korea PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.4.5 Pakistan PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.4.6 Bangladesh PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.4.7 Indonesia PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.4.8 Thailand PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.4.9 Singapore PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.4.10 Malaysia PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.4.11 Philippines PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.4.12 Vietnam PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.5.2 Colombia PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.5.3 Chile PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.5.4 Argentina PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.5.5 Venezuela PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.5.6 Peru PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.5.7 Puerto Rico PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.5.8 Ecuador PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.6.2 Kuwait PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.6.3 Oman PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.6.4 Qatar PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.6.5 Saudi Arabia PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.6.6 United Arab Emirates PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.7.2 South Africa PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.7.3 Egypt PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.7.4 Algeria PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
-
10.8.2 New Zealand PCR and NGS-Based Molecular Diagnostics Consumption (2017-2022)
11 Global PCR and NGS-Based Molecular Diagnostics Competitive Analysis
-
11.1 Burning Rock
-
11.1.1 Burning Rock Company Details
-
11.1.2 Burning Rock PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Burning Rock PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
11.1.4 Burning Rock PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Bioo Scientific
-
11.2.1 Bioo Scientific Company Details
-
11.2.2 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
11.2.4 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Qiagen
-
11.3.1 Qiagen Company Details
-
11.3.2 Qiagen PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Qiagen PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
11.3.4 Qiagen PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Pillar Biosciences
-
11.4.1 Pillar Biosciences Company Details
-
11.4.2 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
11.4.4 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Agilent
-
11.5.1 Agilent Company Details
-
11.5.2 Agilent PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Agilent PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
11.5.4 Agilent PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Paragon Genomics
-
11.6.1 Paragon Genomics Company Details
-
11.6.2 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
11.6.4 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 LC-Bio Technologies (Hangzhou) CO Ltd
-
11.7.1 LC-Bio Technologies (Hangzhou) CO Ltd Company Details
-
11.7.2 LC-Bio Technologies (Hangzhou) CO Ltd PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 LC-Bio Technologies (Hangzhou) CO Ltd PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
11.7.4 LC-Bio Technologies (Hangzhou) CO Ltd PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 iGen Technologies
-
11.8.1 iGen Technologies Company Details
-
11.8.2 iGen Technologies PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 iGen Technologies PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
11.8.4 iGen Technologies PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Thermofisher
-
11.9.1 Thermofisher Company Details
-
11.9.2 Thermofisher PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Thermofisher PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
11.9.4 Thermofisher PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Roche
-
11.10.1 Roche Company Details
-
11.10.2 Roche PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Roche PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
11.10.4 Roche PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Illumine
-
11.11.1 Illumine Company Details
-
11.11.2 Illumine PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Illumine PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
11.11.4 Illumine PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
11.11.5 Recent Research and Development Strategies
12 Global PCR and NGS-Based Molecular Diagnostics Market Outlook by Types and Applications to 2028
-
12.1 Global PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Biomarker Discovery Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Blood Sample Testig Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Academics/Research Institutions Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise PCR and NGS-Based Molecular Diagnostics Market Analysis and Outlook to 2028
-
13.1 Global PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.2.2 Canada PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.2.3 Mexico PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.2 UK PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.3 Spain PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.4 Belgium PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.5 France PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.6 Italy PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.7 Denmark PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.8 Finland PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.9 Norway PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.10 Sweden PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.11 Poland PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.12 Russia PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.13 Turkey PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.2 Japan PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.3 India PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.4 South Korea PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.5 Pakistan PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.7 Indonesia PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.8 Thailand PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.9 Singapore PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.10 Malaysia PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.11 Philippines PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.12 Vietnam PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.5.2 Colombia PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.5.3 Chile PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.5.4 Argentina PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.5.5 Venezuela PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.5.6 Peru PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.5.8 Ecuador PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.6.2 Kuwait PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.6.3 Oman PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.6.4 Qatar PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.7.2 South Africa PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.7.3 Egypt PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.7.4 Algeria PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.8.2 New Zealand PCR and NGS-Based Molecular Diagnostics Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of PCR and NGS-Based Molecular Diagnostics
-
Figure of PCR and NGS-Based Molecular Diagnostics Picture
-
Table Global PCR and NGS-Based Molecular Diagnostics Import by Region (Top 10 Countries) (2017-2028)
-
Table Global PCR and NGS-Based Molecular Diagnostics Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Biomarker Discovery Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Sample Testig Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Academics/Research Institutions Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global PCR and NGS-Based Molecular Diagnostics Consumption by Country (2017-2022)
-
Table North America PCR and NGS-Based Molecular Diagnostics Consumption by Country (2017-2022)
-
Figure United States PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Canada PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Mexico PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Europe PCR and NGS-Based Molecular Diagnostics Consumption by Country (2017-2022)
-
Figure Germany PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure UK PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Spain PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Belgium PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure France PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Italy PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Denmark PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Finland PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Norway PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Sweden PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Poland PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Russia PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Turkey PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Table APAC PCR and NGS-Based Molecular Diagnostics Consumption by Country (2017-2022)
-
Figure China PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Japan PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure India PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Korea PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Pakistan PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Indonesia PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Thailand PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Singapore PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Malaysia PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Philippines PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Vietnam PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Table South America PCR and NGS-Based Molecular Diagnostics Consumption by Country (2017-2022)
-
Figure Brazil PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Colombia PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Chile PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Argentina PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Venezuela PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Peru PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Ecuador PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Table GCC PCR and NGS-Based Molecular Diagnostics Consumption by Country (2017-2022)
-
Figure Bahrain PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Kuwait PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Oman PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Qatar PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Africa PCR and NGS-Based Molecular Diagnostics Consumption by Country (2017-2022)
-
Figure Nigeria PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Africa PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Egypt PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Algeria PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Oceania PCR and NGS-Based Molecular Diagnostics Consumption by Country (2017-2022)
-
Figure Australia PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure New Zealand PCR and NGS-Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Burning Rock Company Details
-
Table Burning Rock PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Burning Rock PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
Table Burning Rock PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
Table Bioo Scientific Company Details
-
Table Bioo Scientific PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bioo Scientific PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
Table Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
Table Qiagen Company Details
-
Table Qiagen PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Qiagen PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
Table Qiagen PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
Table Pillar Biosciences Company Details
-
Table Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
Table Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
Table Agilent Company Details
-
Table Agilent PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agilent PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
Table Agilent PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
Table Paragon Genomics Company Details
-
Table Paragon Genomics PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Paragon Genomics PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
Table Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
Table LC-Bio Technologies (Hangzhou) CO Ltd Company Details
-
Table LC-Bio Technologies (Hangzhou) CO Ltd PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table LC-Bio Technologies (Hangzhou) CO Ltd PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
Table LC-Bio Technologies (Hangzhou) CO Ltd PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
Table iGen Technologies Company Details
-
Table iGen Technologies PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table iGen Technologies PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
Table iGen Technologies PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
Table Thermofisher Company Details
-
Table Thermofisher PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermofisher PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
Table Thermofisher PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
Table Roche Company Details
-
Table Roche PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
Table Roche PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
Table Illumine Company Details
-
Table Illumine PCR and NGS-Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Illumine PCR and NGS-Based Molecular Diagnostics Main Business and Markets Served
-
Table Illumine PCR and NGS-Based Molecular Diagnostics Product Portfolio
-
Figure Global Biomarker Discovery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Sample Testig Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Academics/Research Institutions Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PCR and NGS-Based Molecular Diagnostics Consumption Forecast by Country (2022-2028)
-
Table North America PCR and NGS-Based Molecular Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure United States PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe PCR and NGS-Based Molecular Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Germany PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure France PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC PCR and NGS-Based Molecular Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure China PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table South America PCR and NGS-Based Molecular Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Brazil PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC PCR and NGS-Based Molecular Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Bahrain PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa PCR and NGS-Based Molecular Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Nigeria PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania PCR and NGS-Based Molecular Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Australia PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand PCR and NGS-Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
